Ameke (300896.SZ) simeglutide injection received a notice of approval for drug clinical trials

Zhitong Finance App News, Aimeike (300896.SZ) announced that Beijing Norbot Biotechnology Co., Ltd. (“Norbot Biotech”), a wholly-owned subsidiary of the company, recently received approval from the State Drug Administration to issue a “Drug Clinical Trial Approval Notice” for simeglutide injections and will conduct clinical trials in the near future.

^{This product is used as an adjuvant treatment for a low calorie diet and increased physical activity for adult patients with an initial body mass index (BMI) of at least 28 kg/m2 (obesity), or ≥24 kg/m2 and <28 kg/m2 (overweight) with at least one complication associated with overweight.}